Navigation Links
High Blood Pressure, Cholesterol Associated With Eye Disease
Date:5/12/2008

Risk for retinal vein blockage more than doubles when these conditions go untreated

MONDAY, May 12 (HealthDay News) -- High blood pressure and high cholesterol levels not only are bad for your heart, they may also harm your eyesight, a new report suggests.

The two conditions appear to increase one's risk for retinal vein occlusion, a condition that leads to vision loss. It results from one or more veins carrying blood from the eye to the heart becoming blocked and causing bleeding or fluid build-up, according to background information in the report published in the May issue of the Archives of Ophthalmology.

The Irish study found that people with high blood pressure had more than 3.5 times the risk of developing retinal vein occlusion than those without it. People with high cholesterol levels had an approximately 2.5-fold higher risk of retinal vein occlusion.

The findings come from an analysis of 21 previously published studies involving 2,916 people with retinal vein occlusion and 28,646 people without the condition. It found that 63.6 percent of patients with retinal vein occlusion also had hypertension, compared with 36.2 percent of people without the eye condition. High cholesterol levels were more than twice as likely to be found in those with retinal vein occlusion as those without (35.1 percent vs. 16.7 percent).

Diabetes also occurred slightly more often among those with retinal vein occlusion than among those without (14.6 percent vs. 11.1 percent).

"Accordingly, we recommend that an assessment of blood pressure and both fasting lipid and glucose levels be routinely performed in adults with any form of retinal vein occlusion," the authors wrote.

The authors concluded that those who treat patients with hypertension, diabetes and high cholesterol should be as concerned with the health of the person's eyes as they are with the health of the person's cardiovascular syst
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...nsider change after 30-minute psychosocial interve...HealthDay News) -- A program that gets persistent ...ir dangerous behavior may lead to significant and ... The new study included 184 men and women with two...ere randomly assigned to one of two interventions....
(Date:11/27/2009)...Replikins Ltd. today issued its latest biochemical...s that the lethality of the virus has dropped from...rent outbreak in the spring of 2009 to resting non...H1N1 infectivity count, however, remains increased...er 27, 2009 -- Biotech firm Replikins Ltd., which ...
(Date:11/27/2009)... 27 Shamir Optical Indus...provider of innovative products and technology to ...ts board of directors had declared a dividend dist...(approximately NIS 37.62 million based on the Nove... approximately US$ 0.609 (approximately NIS 2.3 ba...
(Date:11/27/2009)...™ announced today that Spectrum Health (Gran...erprise orthopedic templating solution and its Tra... (PRWEB) November 27, 2009 -- Voyant Heal...and Rapids, Michigan) has licensed its TraumaCad E...raumaCad Extend workflow solution, to allow its or...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...ysician Hospitals of America (PHA) congratulates C...l provide healthcare access and insurance to milli...HA Executive Director. "Congress recognized that ...priately attached to this important package." , ,...
...g Innovations, Inc.,(Nasdaq: YDNT ) today announ...r,31, 2008. , Sales for the fourth quarter of ...n, or 4.5%, from the $25.0 million reported in the...of 2008. Net,income declined 13.0% to $3.1 millio...
...ton John AIDS Foundation announced today that Gram... the 17th Annual Elton John AIDS Foundation (EJAF)...ry 22, 2009, at the Pacific Design Center in Los A...Oakland native Raphael Saadiq made his entree into...
... MedCath Corporation,(Nasdaq: MDTH ), a healthc...vices, predominately the diagnosis and treatment o...ting results for its first quarter of fiscal 2009,... million, -- Operating cash flow from continuin...
...Pharmaceutical Research and Manufacturers of Ameri...he following statement today regarding the State C... Act: , , "President Obama,s signing into law an ...and, indeed, for all Americans -- for we are the f...
...igars at Cigarette Equivalent for First Time , , ...rt indicates a dramatic increase in the use of cig...troubling trend given the popularity of these prod...sumption increased 240 percent, while cigarillos i...
Other Medicine News:Health News:Physician Hospitals of America (PHA) Congratulates Congress on its Passage of a 'Clean' SCHIP Children's Health Bill 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 3Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 4Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 5Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 6Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 7Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 2Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 3Health News:Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party 4Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:MedCath Corporation Reports First Quarter Earnings 13Health News:MedCath Corporation Reports First Quarter Earnings 14Health News:PhRMA Statement on Expansion of SCHIP 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 3Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 4
(Date:11/25/2009)...ATER, N.J., Nov. 25 The FDA grante...rine) tablets, a non-nucleoside reverse transcript... specifically indicated for use in treatment-exper...re with HIV-1 strains resistant to an NNRTI and ot...approval is based on 48-week data from two Phase 3...
(Date:11/25/2009)...EGE PARK, Md., Nov. 25 ... shaving cream-like foam that stops severe bleedin...ng Security Idea category of the Global Security C..., Selected from more than 100 entries from arou...ion at the GSC Security Summit conference held at ...
(Date:11/25/2009)...NG RIDGE, N.J., Nov. 25 Regado Bio...elopment of antithrombotic aptamers with active co... and President, will be presenting at the Piper Ja...w York Palace Hotel in New York City. Dr. Mazzo,s...sday, December 1 and will include an overview of t...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2U S Foodservice Cites Critical Need for Food Safety Culture From Farm to Fork During Monterey PMA Conference 52857 1U S Foodservice Cites Critical Need for Food Safety Culture From Farm to Fork During Monterey PMA Conference 52857 2U S Foodservice Cites Critical Need for Food Safety Culture From Farm to Fork During Monterey PMA Conference 52857 3Mayo researchers find anesthesia not harmful for babies during birth process 52855 1Mayo researchers find anesthesia not harmful for babies during birth process 52855 2Mayo researchers find anesthesia not harmful for babies during birth process 52855 3All in 1 nanoparticle 3A A Swiss Army knife for nanomedicine 9381 1All in 1 nanoparticle 3A A Swiss Army knife for nanomedicine 9381 2All in 1 nanoparticle 3A A Swiss Army knife for nanomedicine 9381 3
...on at ASCO Plenary Session Reports EORTC 40983 (EP...07 /PRNewswire-FirstCall/ -- Results of the,random...OC study,demonstrate for the first time that peri...n(R) (oxaliplatin injection) in,combination with a...-fluorouracil/leucovorin (5-FU/LV)) given to patie...
...Clinical Data on Thalidomide in Multiple Myeloma,P...ogy 43rd Annual,Meeting, CHICAGO, June 04, 2007 /P... reported the final results of a Phase III study,d...tandard therapy,improves overall survival (OS) by ...y diagnosed multiple myeloma compared to the,curre...
Other Medicine Technology:The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 2Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 3Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 6
Viscoelastic Cannula, 27 g. Angled
Anterior Chamber Needle, 25 g. Angled
Hydrodissection / Aspiration Cannula, 25 g. Angled Right
Posterior Capsule Polisher, 23 g
Medicine Products: